| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |